{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:29:24Z","timestamp":1793694564283,"version":"4.5.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00279934"],"award-info":[{"award-number":["RS-2023-00279934"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024 00333544"],"award-info":[{"award-number":["RS-2024 00333544"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.109650","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:28:41Z","timestamp":1790519321000},"page":"109650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Context-dependent PrP\u1d9c signaling in cancer stemness, mesenchymal stromal cell repair, and extracellular vesicle biology"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-8229","authenticated-orcid":false,"given":"Sang Hun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Seob","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.109650_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.109650_bib2","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2026.109650_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbadis.2007.02.011","article-title":"The cellular prion protein (PrP(C)): its physiological function and role in disease","volume":"1772","author":"Westergard","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2026.109650_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1152\/physrev.00007.2007","article-title":"Physiology of the prion protein","volume":"88","author":"Linden","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2026.109650_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmolb.2017.00019","article-title":"Physiological functions of the cellular prion protein","volume":"4","author":"Castle","year":"2017","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.phrs.2026.109650_bib6","first-page":"55","article-title":"PrP\u1d9c from stem cells to cancer","volume":"2","author":"Martin-Lanner\u00e9e","year":"2014","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.phrs.2026.109650_bib7","doi-asserted-by":"crossref","first-page":"31390","DOI":"10.1074\/jbc.M401754200","article-title":"Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt\u2013Jakob disease","volume":"279","author":"Tahiri-Alaoui","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.109650_bib8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","article-title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt\u2013Jakob disease","volume":"352","author":"Palmer","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13974","article-title":"Preventive or promotive effects of PRNP polymorphic heterozygosity on the onset of prion disease","volume":"9","author":"Kai","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2026.109650_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1474-4422(25)00451-X","article-title":"Genetic causes and modifiers of prion diseases","volume":"25","author":"Mead","year":"2026","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2026.109650_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/B978-0-444-63945-5.00015-5","article-title":", Fatal familial insomnia and sporadic fatal insomnia","volume":"153","author":"Cracco","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.phrs.2026.109650_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1110\/ps.051822606","article-title":"Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation","volume":"15","author":"Moore","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib13","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3390\/cancers13092144","article-title":"Prion protein of extracellular vesicle regulates the progression of colorectal cancer","volume":"13","author":"Yun","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.109650_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4062\/biomolther.2017.033","article-title":"Cellular prion protein enhances drug resistance of colorectal cancer cells via regulation of a survival signal pathway","volume":"26","author":"Lee","year":"2018","journal-title":"Biomol. Ther. (Seoul. )."},{"key":"10.1016\/j.phrs.2026.109650_bib15","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1038\/onc.2017.263","article-title":"Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1\u03b1\/GP78 axis","volume":"36","author":"Lee","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2026.109650_bib16","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.21873\/anticanres.15133","article-title":"P.r.P., PrPC regulates the cancer stem cell properties via interaction with c-met in colorectal cancer cells","volume":"41","author":"Lim","year":"2021","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.phrs.2026.109650_bib17","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.21873\/anticanres.14574","article-title":"Role of PrP\u1d9c in cancer stem cell characteristics and drug resistance in colon cancer cells","volume":"40","author":"Go","year":"2020","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.phrs.2026.109650_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12519","article-title":"Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein\u2013Oct4 axis","volume":"65","author":"Lee","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.phrs.2026.109650_bib19","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.21873\/anticanres.12681","article-title":"Melatonin promotes apoptosis of colorectal cancer cells via superoxide-mediated ER stress by inhibiting cellular prion protein expression","volume":"38","author":"Yun","year":"2018","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.phrs.2026.109650_bib20","doi-asserted-by":"crossref","unstructured":"J.H. Lee, Y.M. Yoon, Y.S. Han, C.W. Yun, S.H. Lee, Melatonin promotes apoptosis of oxaliplatin-resistant colorectal cancer cells through inhibition of cellular prion protein 38 Anticancer. Res.2018, 1993200010.21873\/anticanres.12437.","DOI":"10.21873\/anticanres.12437"},{"key":"10.1016\/j.phrs.2026.109650_bib21","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.21873\/anticanres.10989","article-title":"Silencing prion protein in HT29 human colorectal cancer cells enhances anticancer response to fucoidan","volume":"36","author":"Yun","year":"2016","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.phrs.2026.109650_bib22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/ijms27031159","article-title":"PrPC-neutralizing antibody confers an additive benefit in combination with 5-fluorouracil in KRAS-mutant colorectal cancer models, associated with reduced RAS-GTP and AKT\/ERK phosphorylation","volume":"27","author":"Lee","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.310","article-title":"Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells","volume":"7","author":"Han","year":"2016","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.phrs.2026.109650_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12385","article-title":"Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression","volume":"62","author":"Lee","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.phrs.2026.109650_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101144","article-title":"TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrPC","volume":"22","author":"Yoon","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.109650_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12535","article-title":"Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP\u1d9c-dependent enhancement of mitochondrial function","volume":"66","author":"Han","year":"2019","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.phrs.2026.109650_bib27","doi-asserted-by":"crossref","first-page":"39838","DOI":"10.1038\/srep39838","article-title":"Tauroursodeoxycholic acid reduces ER stress by regulating Akt-dependent cellular prion protein","volume":"6","author":"Yun","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.109650_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12632","article-title":"Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem\/stromal cells via cellular prion proteins","volume":"68","author":"Yoon","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.phrs.2026.109650_bib29","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.3892\/mmr.2017.7387","article-title":"Role of hypoxia-mediated cellular prion protein functional change in stem cells and potential application in angiogenesis","volume":"16","author":"Yun","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2026.109650_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/biom11060784","article-title":"Harnessing the physiological functions of cellular prion protein in the kidneys: applications for treating renal diseases","volume":"11","author":"Yoon","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2026.109650_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.109650_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.109650_bib34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular vesicles in cancer: cell-to-cell mediators of metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell."},{"key":"10.1016\/j.phrs.2026.109650_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles."},{"key":"10.1016\/j.phrs.2026.109650_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.phrs.2026.109650_bib37","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.3390\/ijms21239208","article-title":"The cellular prion protein: a promising therapeutic target for cancer","volume":"21","author":"Go","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.742949","article-title":"The role of cellular prion protein in cancer biology: a potential therapeutic target","volume":"11","author":"Ding","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.109650_bib39","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.3390\/cancers13195032","article-title":"The cellular prion protein and the hallmarks of cancer","volume":"13","author":"Mouillet-Richard","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.109650_bib40","doi-asserted-by":"crossref","first-page":"14955","DOI":"10.1073\/pnas.011578098","article-title":"Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation","volume":"98","author":"Ma","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2026.109650_bib41","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1038\/sj.emboj.7600462","article-title":"Protection from cytosolic prion protein toxicity by modulation of protein translocation","volume":"23","author":"Rane","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.109650_bib42","doi-asserted-by":"crossref","first-page":"40877","DOI":"10.1074\/jbc.M306177200","article-title":"Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons","volume":"278","author":"Roucou","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.109650_bib43","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.cdd.4401629","article-title":"Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells","volume":"12","author":"Roucou","year":"2005","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.phrs.2026.109650_bib44","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1091\/mbc.e06-01-0083","article-title":"Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP","volume":"17","author":"Rambold","year":"2006","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.phrs.2026.109650_bib45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12250-019-00107-2","article-title":"Prion protein protects cancer cells against endoplasmic reticulum stress induced apoptosis","volume":"34","author":"Gao","year":"2019","journal-title":"Virol. Sin."},{"key":"10.1016\/j.phrs.2026.109650_bib46","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.7150\/ijms.42603","article-title":"Melatonin protects human renal proximal tubule epithelial cells against high glucose-mediated fibrosis via the cellular prion protein\u2013TGF-\u03b2\u2013Smad signaling axis","volume":"17","author":"Han","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells (Dayt. Ohio)."},{"key":"10.1016\/j.phrs.2026.109650_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2026.109650_bib49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.109650_bib50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.109650_bib51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2026.109650_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O\u2019Brien","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib54","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1158\/0008-5472.CAN-12-3759","article-title":"CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer","volume":"73","author":"Du","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.109650_bib55","doi-asserted-by":"crossref","first-page":"38638","DOI":"10.18632\/oncotarget.9575","article-title":"Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells","volume":"7","author":"Corsaro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.109650_bib56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ebiom.2019.07.036","article-title":"The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer","volume":"46","author":"Le Corre","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2026.109650_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1940674","article-title":"Prognostic value of the PrP\u1d9c\u2013ILK\u2013IDO1 axis in the mesenchymal colorectal cancer subtype","volume":"10","author":"Ghazi","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phrs.2026.109650_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12967-024-05164-0","article-title":"Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer","volume":"22","author":"Mouillet-Richard","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2026.109650_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2026.168334","article-title":"Cellular prion protein suppresses colitis and colorectal carcinogenesis via modulating inflammatory responses","volume":"1872","author":"Zhao","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2026.109650_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1391873","article-title":"PRNP is a pan-cancer prognostic and immunity-related to EMT in colorectal cancer","volume":"12","author":"Chen","year":"2024","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.phrs.2026.109650_bib61","unstructured":"The Human Protein Atlas, PRNP: expression in cancer, Protein Atlas. https:\/\/www.proteinatlas.org\/ENSG00000171867-PRNP\/cancer. (accessed 7 August 2026)."},{"key":"10.1016\/j.phrs.2026.109650_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3205040","article-title":"Downregulated PRNP facilitates cell proliferation and invasion and has effect on the immune regulation in ovarian cancer","volume":"2022","author":"Hu","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2026.109650_bib63","article-title":"Antisense oligonucleotides extend survival of prion-infected mice","volume":"5","author":"Raymond","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2026.109650_bib64","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3390\/ijms22041976","article-title":"PrP\u1d9c aptamer conjugated-gold nanoparticles for targeted delivery of doxorubicin to colorectal cancer cells","volume":"22","author":"Go","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib65","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.21873\/anticanres.18187","article-title":"Milk extracellular vesicle-mediated delivery of siPRNP suppresses growth and wound closure in PC-3M prostate cancer cells","volume":"46","author":"Lee","year":"2026","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.phrs.2026.109650_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.109650_bib67","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2026.109650_bib69","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1159\/000489368","article-title":"C-Met-activated mesenchymal stem cells rescue ischemic damage via interaction with cellular prion protein","volume":"46","author":"Han","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.phrs.2026.109650_bib70","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1634\/stemcells.2007-1000","article-title":"Ex vivo pretreatment with melatonin improves survival, proangiogenic\/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney","volume":"26","author":"Mias","year":"2008","journal-title":"Stem Cells (Dayt. Ohio)."},{"key":"10.1016\/j.phrs.2026.109650_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12545","article-title":"Melatonin protects mesenchymal stem cells from autophagy-mediated death under ischaemic ER-stress conditions by increasing prion protein expression","volume":"52","author":"Lee","year":"2019","journal-title":"Cell. Prolif."},{"key":"10.1016\/j.phrs.2026.109650_bib72","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/ijms19020352","article-title":"Tauroursodeoxycholic acid protects against the effects of p-cresol-induced reactive oxygen species via the expression of cellular prion protein","volume":"19","author":"Yun","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib73","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/ijms20030613","article-title":"TUDCA-treated mesenchymal stem cells protect against ER stress in the hippocampus of a murine chronic kidney disease model","volume":"20","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib74","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/ijms20092314","article-title":"Pioglitazone improves the function of human mesenchymal stem cells in chronic kidney disease patients","volume":"20","author":"Yoon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib75","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/ijms19051367","article-title":"Co-administration of melatonin effectively enhances the therapeutic effects of pioglitazone on mesenchymal stem cells undergoing indoxyl sulfate-induced senescence through modulation of cellular prion protein expression","volume":"19","author":"Han","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109650_bib76","first-page":"242","article-title":"The humanization and maturation of an anti-PrPc antibody","volume":"11","author":"Zhang","year":"2024","journal-title":"Bioeng. (Basel)"},{"key":"10.1016\/j.phrs.2026.109650_bib79","article-title":"Advancing medical applications of cancer nanotechnology","volume":"17","author":"Crist","year":"2025","journal-title":"Highlight two Decades NCI\u2019S. Nanotechnol. Charact. Lab. Serv. Res. Community Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2026.109650_bib81","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/356577a0","article-title":"Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein","volume":"356","author":"B\u00fceler","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib82","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nn.2483","article-title":"Axonal prion protein is required for peripheral myelin maintenance","volume":"13","author":"Bremer","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2026.109650_bib83","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature19312","article-title":"The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6","volume":"536","author":"K\u00fcffer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib84","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1073\/pnas.0510577103","article-title":"Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2026.109650_bib85","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.2018.205716","article-title":"Prion protein deficiency impairs hematopoietic stem cell determination and sensitizes myeloid progenitors to irradiation","volume":"105","author":"Siberchicot","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.phrs.2026.109650_bib86","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12402","article-title":"The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein","volume":"501","author":"Sonati","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109650_bib89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2026.109650_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.109650_bib91","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.phrs.2026.109650_bib92","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.109650_bib93","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ki.2010.278","article-title":"Exosomes\/microvesicles as a mechanism of cell-to-cell communication","volume":"78","author":"Camussi","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2026.109650_bib94","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2016.06.058","article-title":"Extracellular vesicles in renal tissue damage and regeneration","volume":"790","author":"Bruno","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.109650_bib95","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1038\/s41598-019-41100-9","article-title":"Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy","volume":"9","author":"Grange","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.109650_bib96","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1073\/pnas.0308413101","article-title":"Cells release prions in association with exosomes","volume":"101","author":"F\u00e9vrier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2026.109650_bib97","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1099\/jgv.0.000291","article-title":"Detection of cellular prion protein in exosomes derived from ovine plasma","volume":"96","author":"Berrone","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.phrs.2026.109650_bib98","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.neuron.2018.08.010","article-title":"Muskelin Coordinates PrPC Lysosome versus Exosome Targeting and Impacts Prion Disease Progression","volume":"99","author":"Heisler","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.109650_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101642","article-title":"Cellular prion protein in human plasma-derived extracellular vesicles promotes neurite outgrowth via the NMDA receptor\u2013LRP1 receptor system","volume":"298","author":"Gonias","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.109650_bib100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4049\/jimmunol.2100412","article-title":"A soluble PrPC derivative and membrane-anchored PrPC in extracellular vesicles attenuate innate immunity by engaging the NMDA-R\/LRP1 receptor complex","volume":"208","author":"Mantuano","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109650_bib101","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1809065","article-title":"Characterization of brain-derived extracellular vesicles reveals changes in cellular origin after stroke and enrichment of the prion protein with a potential role in cellular uptake","volume":"9","author":"Brenna","year":"2020","journal-title":"J. Extracell. Vesicles."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:07:17Z","timestamp":1793693237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826015653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":96,"alternative-id":["S1043661826015653"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109650","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Context-dependent PrP\u1d9c signaling in cancer stemness, mesenchymal stromal cell repair, and extracellular vesicle biology","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109650"}}